Cargando…
Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine
BACKGROUND: Carcinoma ex pleomorphic adenoma is a rare histologic subtype of salivary gland cancer with an overall poor prognosis. Limited histopathologic analyses have shown that some such tumors exhibit significant HER2/neu immunoreactivity, suggesting a potential role for HER2-based therapy. We r...
Autores principales: | Sharon, Elad, Kelly, Ronan J, Szabo, Eva |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2889991/ https://www.ncbi.nlm.nih.gov/pubmed/20504363 http://dx.doi.org/10.1186/1758-3284-2-12 |
Ejemplares similares
-
Immunohistochemical Expression of p53 in Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma
por: Tarakji, Bassel, et al.
Publicado: (2010) -
BRCA1/2 Mutations in Salivary Pleomorphic Adenoma and Carcinoma-ex-Pleomorphic Adenoma
por: Irani, Soussan, et al.
Publicado: (2017) -
Ossifying Parotid Carcinoma ex Pleomorphic Adenoma
por: Mohan, Suresh, et al.
Publicado: (2015) -
Quantitative promoter methylation differentiates carcinoma ex pleomorphic adenoma from pleomorphic salivary adenoma
por: Schache, A G, et al.
Publicado: (2010) -
CD44 expression in pleomorphic adenoma, carcinoma ex pleomorphic adenoma and their adjacent normal salivary glands
por: Shamloo, Nafiseh, et al.
Publicado: (2018)